Drug class
Amidinopenicillin beta-lactam antibacterial; oral prodrug of mecillinam
Mechanism of action
Pivmecillinam is rapidly hydrolysed to mecillinam, which inhibits bacterial cell-wall biosynthesis by preferentially binding penicillin-binding protein 2 (PBP-2) in Gram-negative bacteria.
General use cases
- Treatment of uncomplicated urinary tract infections in adult women caused by susceptible Escherichia coli, Proteus mirabilis or Staphylococcus saprophyticus, under the current product label.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
